[1] |
ZENG Lijie, WANG Liang, YANG Lei .
Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
|
[2] |
LI Mengjiao, CEN Yali, DOU Baitao, SHU Rou, LI Yanling, QIU Ling, REN Shihui, YAO Hao, FAN Fangyi.
Advances in the application of molecular targeted drugs combined with CAR-T cell therapy in lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 532-539.
|
[3] |
LYU Liwei, CONG Jia, WU Yiping, WANG Liang .
BCMA CAR-T cell therapy for relapsed/refractory plasmablastic lymphoma: case report and clinical implication
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 562-565.
|
[4] |
BI Jianghan, ZHANG Yan, WANG Wei .
Glofitamab therapy under the dual challenge of novel coronavirus infection and CAR-T resistance: a case report of refractory diffuse large B-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 566-570.
|
[5] |
HE Ying, LI Mengjiao, CEN Yali, DOU Baitao, SHU Rou, LI Yanling, YAO Hao, FAN Fangyi.
CD19 CAR T-cell therapy: a case of refractory primary central nervous system diffuse large B-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 571-576.
|
[6] |
YANG Lei, ZENG Lijie, TAO Jianhua, YAO Na, CONG Jia, YANG Jing, WANG Henan, WEI Liqiang, WANG Liang.
Clinical analysis of extranodal NK/T-cell lymphoma,nasal type,manifesting with primary ocular lesions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 321-326.
|
[7] |
WU Hualing, LIN Qing .
Analysis of clinical and dosimetric factors related to radiation pneumonitis after intensity-modulated radiotherapy in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 327-331.
|
[8] |
ZHANG Kaimin, HUANG Yujie, DUAN Ying, GUO Baoping, KE Qing, LIAO Chengcheng, CEN Hong .
Anti⁃tumor effect of PI3K inhibitor Linperlisib on diffuse large B⁃cell lymphoma in vitro
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 56-61.
|
[9] |
WANG Yong, ZHOU Yuling, ZHOU Qionghui, ZENG Biao, HU Ying.
Application of 3D printing compensation film in postoperation radiotherapy of immediate breast reconstruction for breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 96-100.
|
[10] |
GUO Jia, WANG Chengji, LIANG Yuanzheng, WANG Liang.
Clinical analysis of rituximab-induced interstitial lung disease in newly treated patients with diffuse large B-cell lymphoma: A retrospective study of single-center
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(4): 391-397.
|
[11] |
QIU Jialin, LIANG Shixiong, LI Jianxu, QIU Moqin, LONG Meiying, JIANG Yanji, HE Meiling, WEI Xueyan, YU Hongping.
Prognostic factors for hepatocellular carcinoma of China liver cancer staging Ⅲ after radiotherapy and prediction nomogram construction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 195-201.
|
[12] |
WEI Chong, ZHAO Danqing, ZHANG Yan, WANG Wei, ZHANG Wei, ZHOU Daobin .
Chidamide combined with azacitidine in treating relapsed/refractory angioimmunoblastic T⁃cell lymphoma: a prospective clinical study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 51-55.
|
[13] |
ZHANG Xuefang, DIAO Xiaoli, WANG Shuzhen.
Primary ovarian diffuse large B⁃cell lymphoma: 4 cases report and literature review
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(6): 653-658.
|
[14] |
FU Ruiying, LIU Xindi, LIANG Yuanzheng, LIU Xuelin, WANG Liang.
The role of lncRNA BCYRN1 in activation of glycolysis in extranodal NK/T⁃cell lymphoma and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(4): 370-377.
|
[15] |
HOU Guangying, MIAO Junjun, HU Jianwei, GAO Lei, ZHANG Yongxia, YUAN Xiangkun.
Efficacy analysis of 3D⁃printed minimally invasive⁃guided template interstitial radiotherapy combined with deep hyperthermia in the treatment of
locally advanced cervical cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(1): 76-81.
|